You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

Litigation Details for Celgene Corporation v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2020)


✉ Email this page to a colleague

« Back to Dashboard


Celgene Corporation v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2020)

Docket ⤷  Try a Trial Date Filed 2020-01-02
Court District Court, N.D. West Virginia Date Terminated 2021-07-23
Cause 35:145 Patent Infringement Assigned To Irene Patricia Murphy Keeley
Jury Demand None Referred To Robert W. Trumble
Parties MYLAN INC.
Patents 7,189,740; 7,465,800; 7,855,217; 7,968,569; 8,404,717; 8,530,498; 8,648,095; 9,056,120; 9,101,621; 9,101,622
Attorneys Thomas D. Pease
Firms Simmerman Law Office, PLLC
Link to Docket External link to docket
Small Molecule Drugs cited in Celgene Corporation v. Mylan Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Try a Trial .
Biologic Drugs cited in Celgene Corporation v. Mylan Pharmaceuticals Inc.
The biologic drugs covered by the patents cited in this case are ⤷  Try a Trial and ⤷  Try a Trial .

Details for Celgene Corporation v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-01-02 1 Complaint (NOT for attorney use) United States Patent Nos. 7,189,740 (“the ‘740 patent”), 7,465,800 (“the ‘800 patent”), 7,855,217 (“…740 patent, the ‘800 patent, the ‘217 patent, the ‘569 patent, the ‘717 patent, the ‘498 patent, the …‘740 patent, the ‘800 patent, the ‘217 patent, the ‘569 patent, the ‘717 patent, the ‘498 patent, the…(“the ‘217 patent”), 7,968,569 (“the ‘569 patent”), 8,404,717 (“the ‘717 patent”), 8,530,498 (“the ‘498…‘498 patent”), 8,648,095 (“the ‘095 patent”), 9,056,120 (“the ‘120 patent”), 9,101,621 (“the ‘621 patent External link to document
2020-09-04 112 Amended Complaint United States Patent Nos. 7,189,740 (“the ’740 patent”), 7,465,800 (“the ’800 patent”), 7,855,217 … patent, the ’800 patent, the ’217 patent, the ’569 patent, the ’717 patent, the ’498 patent, the … of the ’740 patent, the ’800 patent, the ’217 patent, the ’569 patent, the ’717 patent, the ’498 … patent, the ’095 patent, the ’120 patent, and the ’622 patent are invalid, unenforceable, and/or …7,855,217 (“the ’217 patent”), 7,968,569 (“the ’569 patent”), 8,404,717 (“the ’717 patent”), 8,530,498 (“the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.